07:00 , May 11, 2015 |  BC Week In Review  |  Clinical News

Toviaz fesoterodine regulatory update

FDA granted tentative approval to an ANDA from Amerigen Pharmaceuticals Ltd. (Lyndhurst, N.J.) for a generic version of Toviaz fesoterodine to treat overactive bladder (OAB). Pfizer has exclusive, worldwide rights from UCB to Toviaz. The...
08:00 , Nov 18, 2013 |  BC Week In Review  |  Company News

Actavis Inc., Alkem Laboratories, Amerigen Pharmaceuticals Ltd., Forest Laboratories, Glenmark, Hetero Drugs Ltd., Indchemie Health Specialties Pvt. Ltd., Torre

Forest settled two lawsuits that alleged the generic companies' ANDAs for generic versions of hypertension drug Bystolic nebivolol infringed U.S. Patent No. 6,545,040. In March 2012, Forest filed Forest Laboratories Inc. et al v. Torrent...
07:00 , Aug 5, 2013 |  BC Week In Review  |  Company News

Amerigen Pharmaceuticals, Forest Laboratories deal

Forest invested in Amerigen's early stage generics development program in exchange for royalties on U.S. sales and an option to acquire rights to commercialize the products in Latin America. Amerigen will use its formulation expertise...
07:00 , Jul 29, 2013 |  BC Week In Review  |  Company News

Amerigen Pharmaceuticals Ltd., Forest Laboratories cardiovascular news

Forest and Amerigen settled a March 2012 patent suit claiming Amerigen's ANDA for a generic version of hypertension drug Bystolic nebivolol infringes Forest's U.S. Patent No. 6,545,040. The patent covers methods of treating hypertension with...
08:00 , Jan 7, 2013 |  BC Week In Review  |  Company News

Forest Laboratories, Glenmark cardiovascular news

Forest and Glenmark settled a March 2012 patent suit claiming Glenmark's ANDA for a generic version of hypertension drug Bystolic nebivolol infringes Forest's U.S. Patent No. 6,545,040. The patent covers methods of treating hypertension with...
07:00 , Mar 19, 2012 |  BC Week In Review  |  Company News

Watson Laboratories Inc., Alkem Laboratories, Amerigen Pharmaceuticals Ltd., Forest Laboratories, Glenmark, Hetero Drugs, Indchemie Health Specialties Pvt. Ltd.

Forest and Johnson & Johnson's Janssen Pharmaceutica N.V. unit filed suit against Amerigen, Glenmark, Hetero Drugs, Torrent and Watson in the U.S. District Court for the District of Delaware claiming ANDAs for generic versions of...